Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Graft vs Host Disease × peginterferon alfa-2b × 1 year × Clear all

Sponsor

Conditions

Thrombocytosis 1 Ovarian Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Meningeal Carcinomatosis 1 Melanoma 1 Leukemia-Lymphoma, Adult T-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Fallopian Tube Neoplasms 1 Carcinoma 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 14 Mycophenolic Acid 10 Tacrolimus 9 fludarabine 7 ruxolitinib 6 Whole-Body Irradiation 5 Melphalan 5 Busulfan 5 fludarabine phosphate 4 Sirolimus 4 Methotrexate 4 Hematopoietic Stem Cell Transplantation 3 ibrutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Specimen Handling 2 Radiotherapy 2 Cyclosporine 2 Biopsy 2 Abatacept 2 vedolizumab 1 tildrakizumab 1 itacitinib 1 interferon gamma-1b 1 blinatumomab 1 belumosudil 1 axatilimab 1 Vorinostat 1 Tomography, Optical Coherence 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡